v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
Grant revenue $ 76 $ 342
Operating expenses:    
Research and development 21,372 14,332
General and administrative 6,985 7,842
Total operating expenses 28,357 22,174
Operating loss (28,281) (21,832)
Non-operating income (expense):    
Interest income 2,197 2,384
Interest and other expense (105) (128)
Other income from a related party (Note 3) 0 1,400
Equity in loss of affiliate 0 (1)
Total non-operating income, net 2,092 3,655
Net loss $ (26,189) $ (18,177)
Basic loss per share $ (0.25) $ (0.25)
Diluted loss per share $ (0.25) $ (0.25)
Weighted average number of shares used in computing net loss per share:    
Basic 103,604 72,357
Diluted 103,604 72,357
Unrealized (loss) gain on available-for-sale securities $ (336) $ 70
Comprehensive loss $ (26,525) $ (18,107)